Wednesday 19 November

Full Day Clinical Trials Workshop

9am - 5pm

Workshop 1: Operational And Statistical Issues In Adaptive Platform Trials

Adaptive Platform Trials (APTs) are a flexible trial design that enable multiple interventions within different treatment modalities (domains) to be compared simultaneously in one or more patient groups where interventions be added or removed as the study progresses based on pre-defined decision rules. APTs offer efficiency in time and cost compared with conventional designs, but are much more complex to design and operate. This workshop, presented by a range of researchers with experience in APTs, provides an opportunity to learn from others and to discuss issues in designing and conducting APTs.

The morning will focus on operational issues in APTs, covering topics such as sponsorship, ethics, contracts, databases, consumer engagement funding and creating a community of practice. In the afternoon, we will focus on statistical issues of simulation for trial design, statistical documentation and the development, validation and analysis of ordinal outcomes.

The workshop is aimed at researchers and statisticians working in or considering embarking on establishing an APT. Working knowledge of APTs will be assumed.



Wednesday 19 November

Half Day Clinical Trials Workshops

9am - 1pm

Workshop 2: Costing Implementation Strategies (COST-IS) And Enhancing Economic Evaluations In Trials

It is important to determine the relative value of healthcare innovations when allocating limited healthcare resources. Implementation strategies require and consume healthcare resources yet are often excluded from published economic evaluations.

The learning objectives of this workshop are:

  • Understand the role of both economic evaluations and implementation outcomes in trials, including how they relate to each other and contribute to effective research translation
  • Recognise and assess implementation-related costs and their importance in determining the value of interventions
  • Gain experience in practical applications of Cost-IS


Facilitated by: Thomasina Donovan and Lane Carrandi


Workshop 3: Demystifying Intersectionality In Clinical Trials: From Theory To Practice

This session will feature presenters from diverse fields – ethics, qualitative research, consumer and community involvement, implementation science, Indigenous health – to prompt the audience to reflect on WHAT intersectionality is and HOW it can be applied in clinical trials to make research and healthcare more socially aware, inclusive and just.

The session will have interactive elements to extend the discussion on how to use intersectionality to make clinical trials more inclusive and just, ultimately reducing health inequities in research and in the real world. Participants will leave with a clearer understanding of how to foster equitable and inclusive trial design and implementation through an intersectional lens.


Facilitated by: Prof Nik Zeps, Dr Bec Jenkinson, Dr Mark Liu & Prof Dan McAulley


Workshop 4: Title TBC

Workshop overview TBC




Wednesday 19 November

Half Day Clinical Trials Workshop

2pm - 5pm

Workshop 5: Addressing Inequities And Access To Clinical Trials For Indigenous Australians

This safe and creative workshop will deliver a facilitated conversation that explores both the barriers experienced by Indigenous Australians in accessing clinical trials and the opportunities that can address these existing inequities and increase their participation in research.

The workshop facilitators will lead participants through an expert-guided series of presentations and group discussions that identify the ways in which culturally appropriate and safe services and staff can positively impact on the lives of Indigenous participants and their families. The facilitation team includes expert knowledge holders from the Aboriginal heath service sector, Indigenous genomics research, Indigenous data sovereignty and governance and the pharmaceutical industry.

This is a unique opportunity to learn and apply new and co-designed knowledge and methods within clinical trials environments to increase an under-represented clinical trials participant cohort – Indigenous Australians.


Facilitated by: Louise Lyons, The Kids Research Institute Australia

Australian Clinical Trials Alliance

© Copyright 2025 | ACTA | All Rights Reserved